Global Business Development

Christian J. Suojanen

Launched in 2007 at the request of his 3 fellow members of the European Biotech Action Committee (2006-2008, comprised of the Presidents or Executive Directors of each the European Venture Capital Association, EuropaBio, EBE/EFPIA, European Federation of Biotechnology, and high level observers from the EC  and European Investment Bank) to improve the translation of Europe’s world class research to market, in 2009 the TTS Global Initiative was formalized and in addition to training courses and tech transfer and innovation strategy advisory for institutions, national tech transfer systems and regional health systems, has organized over 20 summits around the world, including editions hosted on campus at the NIH, UCSF together with Bay Bio and the UC System, Johns Hopkins, Rutgers, University of Illinois, Weil Cornell Medical, University of Miami, by the Wellcome Trust, the Pasteur Institute, Inserm and the Paris Chamber of Commerce, A*STAR and ETPL Singapore, AusBiotech, BIOTECanada, CORFO Chile, Colciencia Colombia…


He was the lead advisor, dialogue moderator and “rapporteur” for the European Commission’s 3 year strategic “Innovation in Healthcare” initiative to revise innovation funding policy based on stakeholder input from senior representatives of Europe’s leading biotech and pharma sector industry, VCs, biotech CEOs, and technology transfer offices, who he recruited and brought together in a series of working groups he chaired and in annual summits with European Commissioners and EC officials, at which he was the lead moderator.

Recruited by the European Commission (2004), he led a turn-around of Europe’s largest biotech association, taking it from the verge of bankruptcy with intra- executive litigation imminent, he brought the association back from the brink of bankruptcy, grew membership, more than tripled revenues, launched multiple international collaborations in the BRICS, developed a new peer-reviewed journal, and revived a failed international scientific congress to hold the most international biotech meeting ever organized at that time in Europe, with over 1700 high level scientific and industry representatives from 65 countries participating.


He coordinated the first European level entrepreneur training and boot camp and venture academy for biotech founders/CEOs (1999), hosted by IESE business school, built the first European biotech investment initiative in collaboration with the European Commission and EASDAQ (now Euronext) and in coordination with industry and investors, and has extensive experience coaching & mentoring entrepreneurs, CEOs and tech transfer directors.


Christian has deep cross functional sector expertise and an exceptional international network of key innovation stakeholders from industry, finance, SMEs & research and is fluent in English, French and Spanish.